Effect of 5-fluorouracil combination therapy on RNA processing in human colonic carcinoma cells.
We have evaluated the RNA-directed cytotoxicity of 5-fluorouracil (5-FU) in human colonic carcinoma cells. The mode of action of 5-FU and its effects on human pre-rRNA processing were then examined. From these data, possible reasons why the disruption of pre-rRNA maturation could induce cytotoxic effects are considered. The results imply that inhibition of thymidylate synthase is not the sole primary cytotoxic lesion in this cell line. First, exogenous thymidine (dTHd) enchanced cytotoxicity. Second, addition of dThd to the cells was found to enhance incorporation of 5-FU into total cellular RNA. Third, 5-FU disrupted rRNA processing by a different mechanism from actinomycin D and methotrexate (MTX), suggesting that the inhibition was not just a consequence of cell death. Finally, the addition of dThd was found to enhance the disruption of rRNA processing consistent with an increase in concentration of 5-FU. These data are discussed in the light of literature reports and their potential for optimising 5-FU protocols.
Greenhalgh
D A
DA
Department of Biochemistry, University of Leeds, U.K.
Parish
J H
JH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology; D002466:Cell Nucleolus / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects*; D012334:RNA, Neoplasm / Q000187:drug effects / Q000378:metabolism*; D012335:RNA, Ribosomal / Q000187:drug effects / Q000378:metabolism; D013936:Thymidine / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D012334:RNA, Neoplasm; D012335:RNA, Ribosomal; D005472:Fluorouracil; D013936:Thymidine